Panfeng Fu to Disease Models, Animal
This is a "connection" page, showing publications Panfeng Fu has written about Disease Models, Animal.
Connection Strength
0.135
-
Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2020 09 01; 319(3):L497-L512.
Score: 0.029
-
Genetic deletion of Sphk2 confers protection against Pseudomonas aeruginosa mediated differential expression of genes related to virulent infection and inflammation in mouse lung. BMC Genomics. 2019 Dec 16; 20(1):984.
Score: 0.028
-
Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. Am J Respir Cell Mol Biol. 2013 Dec; 49(6):912-22.
Score: 0.018
-
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med. 2013 Oct 15; 188(8):928-40.
Score: 0.018
-
p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury. Exp Cell Res. 2011 Apr 01; 317(6):859-72.
Score: 0.015
-
Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling. Transl Res. 2010 Jan; 155(1):44-54.
Score: 0.014
-
Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res. 2009 Apr 24; 104(8):978-86.
Score: 0.013